Mathias Vormehr
Impact in
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Immunology 21
- Immunotherapy and Immune Responses 20
- Immune Cell Function and Interaction 4
- T-cell and B-cell Immunology 2
- Oncology 17
- Cancer Immunotherapy and Biomarkers 12
- CAR-T cell therapy research 11
- Co-authors
- Uğur Şahin (20 shared papers)Özlem Türeci (15 shared papers)Mustafa Diken (15 shared papers)Sebastian Kreiter (14 shared papers)Sebastian Boegel (5 shared papers)Barbara Schrörs (5 shared papers)Martin Löwer (5 shared papers)Christoph Huber (2 shared papers)
- Journals
- OncoImmunology (4 papers)Cancer Immunology Research (2 papers)Cancer Cell (1 paper)Clinical Cancer Research (1 paper)Human Vaccines & Immunotherapeutics (1 paper)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Mathias Vormehr
23 papers receiving 1.8k citations
Mathias Vormehr's Hit Papers
Peers
Comparison fields: 5 of 80
- Immunology 1.2k
- Oncology 990
- Molecular Biology 850
- Cancer Research 136
- Radiology, Nuclear Medicine and Imaging 143
Countries citing papers authored by Mathias Vormehr
This map shows the geographic impact of Mathias Vormehr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathias Vormehr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathias Vormehr more than expected).
Fields of papers citing papers by Mathias Vormehr
This network shows the impact of papers produced by Mathias Vormehr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathias Vormehr. The network helps show where Mathias Vormehr may publish in the future.
Co-authors
The 25 scholars most cited alongside Mathias Vormehr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mutant MHC class II epitopes drive therapeutic immune responses to cancer Hit paper breakdown → | 2015 | 915 |
| 2 | mRNA therapeutics in cancer immunotherapy Hit paper breakdown → | 2021 | 272 |
| 3 | 2020 | 141 | |
| 4 | 2016 | 109 | |
| 5 | 2019 | 76 | |
| 6 | 2020 | 55 | |
| 7 | 2015 | 48 | |
| 8 | 2020 | 41 | |
| 9 | 2024 | 34 | |
| 10 | 2015 | 34 | |
| 11 | 2019 | 21 | |
| 12 | 2020 | 17 | |
| 13 | 2018 | 13 | |
| 14 | 2023 | 9 | |
| 15 | 2016 | 9 | |
| 16 | 2019 | 7 | |
| 17 | 2018 | 4 | |
| 18 | 2024 | 3 | |
| 19 | Actively personalized cancer vaccines--the step into clinical application. | 2016 | 3 |
| 20 | 2020 | 2 |
About Mathias Vormehr
Mathias Vormehr is a scholar working on Immunology, Oncology, Molecular Biology, Epidemiology and Genetics, having authored 23 papers that have together received 1.8k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (20 papers), Cancer Immunotherapy and Biomarkers (12 papers), CAR-T cell therapy research (11 papers), vaccines and immunoinformatics approaches (6 papers), Immune Cell Function and Interaction (4 papers), RNA Interference and Gene Delivery (3 papers), Cancer Research and Treatments (2 papers) and T-cell and B-cell Immunology (2 papers). The work is most often cited by research in Immunology (1.2k citations), Oncology (990 citations), Molecular Biology (850 citations), Cancer Research (136 citations) and Radiology, Nuclear Medicine and Imaging (143 citations). Mathias Vormehr has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Uğur Şahin, Özlem Türeci, Mustafa Diken, Sebastian Kreiter, Sebastian Boegel, Barbara Schrörs, Martin Löwer, Christoph Huber, Arbel D. Tadmor and Fulvia Vascotto. Their work appears in journals such as OncoImmunology, Cancer Immunology Research, Cancer Cell, Clinical Cancer Research and Human Vaccines & Immunotherapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.